SCHEMBL8285283

SCHEMBL8285283

CN(Cc1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.57
WEE1 P30291 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
CYP1A2 P05177 1/20 0.32
GSK3B P49841 2/20 0.32
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
GAA P10253 1/20 0.31
PTK2 Q05397 1/20 0.31
CDK4 P11802 1/20 0.30
CCND1 P24385 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285270 0.88 PDE11A (0.58) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8285269 0.88 PDE11A (0.54) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8285287 0.84 PDE11A (0.63) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8287847 0.84 PDE11A (0.60) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8285267 0.84 PDE11A (0.62) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8287507 0.83 PDE11A (0.59) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8285258 0.83 PDE11A (0.55) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8287500 0.81 PDE11A (0.57) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8285257 0.81 PDE11A (0.57) PDE11AWEE1MEN1KMT2ACNR1
SCHEMBL8285254 0.81 PDE11A (0.59) PDE11AWEE1MEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed